戴津的GABAergic抗抑郁作用:在体内方法与in silico受体结合 afinities 的方法
Md Torequl Islam1,2,3, Md Showkot Akbor2,3, Md Shimul Bhuia2,3
1Pharmacy Discipline, Khulna University, Khulna, 9208 Bangladesh.
In silico pharmacology
|April 18, 2025
概括
一种大豆异黄的戴津 (DZN) 通过与GABAA受体相互作用,在小鼠中显示出潜在的抗抑郁活性. DZN增强了静止时间,并与迪亚泽巴姆协同作用,表明了一种新的治疗途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 自然产品 自然产品
背景情况:
- 大津 (DZN) 是一种具有已知的生物活性的大豆异黄,包括保护性,抗焦虑,增强记忆力和抗作用.
- 戴津的抗抑郁药潜力以前没有被研究,这代表了对其神经药理学特征的理解存在差距.
研究的目的:
- 通过实体动物模型和实体计算机计算研究,研究Daidzin (DZN) 的抗抑郁活性.
- 探索DZN抗抑郁作用的潜在分子机制,特别是与GABAergic系统的相互作用.
主要方法:
- 在行为测试中使用了男性瑞士白色老鼠,分成接受车辆,不同剂量的DZN (5,10,20毫克/公斤),迪亚泽帕姆,弗卢马塞尼尔或组合的小组.
- 在基分子对接研究中进行了评估DZN与GABAA受体亚型的结合亲和力.
主要成果:
- 戴津 (DZN) 显示出剂量依赖且显著增加不运动时间 (IMT),这是抗抑郁药类活性的标志物.
- DZN (10毫克/公斤) 显著增强了迪亚泽巴姆 (GABAA激动剂) 的作用,并对抗了弗卢马泽尼尔 (GABAA激动剂) 的作用.
- 在分析中发现,DZN与GABAA受体亚型的结合亲和力很强.
结论:
- 戴津 (DZN) 在小鼠中表现出显著的抗抑郁药类活性,可能通过与GABAA受体的相互作用进行介导.
- DZN 显示了与迪亚泽巴姆的协同作用,进一步支持其对GABAergic 系统的调节.
- 这些发现表明,DZN是作为一种新型抗抑郁药物进一步研究的有希望的候选人.
相关概念视频
G-protein Coupled Receptors
112.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
112.3K
The Two-State Receptor Model
1.8K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.8K
G Protein-coupled Receptors
10.7K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
10.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K


